| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |